Expression of inhibins in the endometrial carcinoma cell line RL-95-2 after stimulation with cortisol and estradiol

Anticancer Research

Volumn 27, Issue 4 A, 2007, Pages 1989-1993

  Vogl, Julia ^a   Höing, Anna ^a   Schulze, Sandra ^a   Kuhn, Christina ^a   Wiest, Irmi ^a   Shabani, Naim ^a   Jeschke, Udo ^a   Mylonas, Ioannis ^a   Friese, Klaus ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cortisol; Endometrial cancer; Estradiol; Inhibins; RL 95 2

Indexed keywords

ACTIVIN; ESTRADIOL; HYDROCORTISONE; INHIBIN; INHIBIN ALPHA; INHIBIN BETA A; INHIBIN BETA B; UNCLASSIFIED DRUG;

CARCINOMA CELL; CELL STIMULATION; CONFERENCE PAPER; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

CELL LINE, TUMOR; ENDOMETRIAL NEOPLASMS; ESTRADIOL; FEMALE; GENE EXPRESSION; HUMANS; HYDROCORTISONE; IMMUNOHISTOCHEMISTRY; INHIBINS;

EID: 34250719610     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (24)

1. Vale W, Rivier C, Hsueh A, Campen C, Meunier H, Bicsak T, Vaughan J, Corrigan A, Bardin W, Sawchenko P et al: Chemical and biological characterization of the inhibin family of protein hormones. Recent Prog Horm Res 44: 1-34, 1988.
2. Welt CK: Regulation and function of inhibins in the normal menstrual cycle. Seminars in Reproductive Medicine 22: 187-193, 2004.
3. Sherman ME: Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol 13: 295-308, 2000.
4. Mylonas I, Jeschke U, Winkler L, Makovitzky J, Richter DU, Briese V and Friese K: Immunohistochemical expression of inhibin-alpha in human endometrium and the in vitro secretion of inhibin, estradiol and cortisol in cultured human endometrial glandular cells. Arch Gynecol Obstet 268: 142-150, 2003.
5. Mylonas I, Winkler L, Jeschke U, Briese V and Friese K, Investigations on isolation, purification and cultivation of human endometrial cells and on the in vitro inhibin expression in glandular epithelial cells. Zentralbl Gynakol 125: 415-423, 2003.
6. Mylonas I, Makovitzky J, Fernow A, Richter DU, Jeschke U, Briese V, Gerber B and Friese K: Expression of the inhibin/activin subunits alpha (alpha), beta-A (betaA) and beta-B (betaB) in benign human endometrial polyps and tamoxifen-associated polyps. Arch Gynecol Obstet 272: 59-66, 2005.
7. Petraglia F, Florio P, Luisi S, Gallo R, Gadducci A, Vigano P, Di Blasio AM, Genazzani AR and Vale W: Expression and secretion of inhibin and activin in normal and neoplastic uterine tissues. High levels of serum activin A in women with endometrial and cervical carcinoma. J Clin Endocrinol Metab 83: 1194-1200, 1998.
8. Mylonas I, Makovitzky J, Richter DU, Jeschke U, Briese V and Friese K: Expression of the inhibin-alpha subunit in normal, hyperplastic and malignant endometrial tissue: an immunohistochemical analysis. Gynecol Oncol 93: 92-97, 2004.
9. Mylonas I, Makovitzky J, Hoeing A, Richter DU, Vogl J, Schulze S, Jeschke U, Briese V and Friese K: Inhibin/activin subunits beta-A (-betaA) and beta-B (-betaB) are differentially localised in normal, hyperplastic and malignant human endometrial tissue. Acta Histochem 108: 1-11, 2006.
10. Oreskovic S, Babic D, Kalafatic D, Barisic D and Beketic-Oreskovic L: A significance of immunohistochemical determination of steroid receptors, cell proliferation factor Ki-67 and protein p53 in endometrial carcinoma. Gynecol Oncol 93: 34-40, 2004.
11. Way DL, Grosso DS, Davis JR, Surwit EA and Christian CD: Characterization of a new human endometrial carcinoma (RL95-2) established in tissue culture. In Vitro 19: 147-158, 1983.
12. Remmele W and Stegner HE: Vorschlag zur einheitlichen Definierung eines immunreaktiven Score (IRS) für den immunhistochemischen Östrogenrezeptornachweis (ER-ICA) im Mammakarzinomgewebe. Pathologe 8: 138-140, 1987.
13. Mylonas I, Makovitzky J, Richter DU, Briese V, Jeschke U and Friese K: Expression of cytokeratins and vimentin in normal human endometrial cells in vitro: an immunohistochemical analysis on isolated glandular epithelial cells. Anticancer Res 20: 5125-5128, 2000.
14. Yamaguchi M, Mizunuma H, Miyamoto K, Hasegawa Y, Ibuki Y and Igarashi M: Immunoreactive inhibin concentrations in adult men: presence of a circadian rhythm. J Clin Endocrinol Metab 72: 554-559, 1991.
15. Munro LM, Kennedy A and McNicol AM: The expression of inhibin/activin subunits in the human adrenal cortex and its tumours. J Endocrinol 161: 341-347, 1999.
16. Voutilainen R, Eramaa M and Ritvos O: Hormonally regulated inhibin gene expression in human fetal and adult adrenals. J Clin Endocrinol Metab 73: 1026-1030, 1991.
17. Chabbert Buffet N, Djakoure C, Maitre SC and Bouchard P: Regulation of the human menstrual cycle. Front Neuroendocrinol 19: 151-186, 1998.
18. Woodruff TK, Lyon RJ, Hansen SE, Rice GC and Mather JP: Inhibin and activin locally regulate rat ovarian folliculogenesis. Endocrinology 127: 3196-3205, 1990.
19. Hillier SG, Yong EL, Illingworth PJ, Baird DT, Schwall RH and Mason AJ: Effect of recombinant activin on androgen synthesis in cultured human thecal cells. J Clin Endocrinol Metab 72: 1206-1211, 1991.
20. Smyth CD, Gosden RG, McNeilly AS and Hillier SG: Effect of inhibin immunoneutralization on steroidogenesis in rat ovarian follicles in vitro. J Endocrinol 140: 437-443, 1994.
21. Mylonas I, Jeschke U, Wiest I, Hoeing A, Vogl J, Shabani N, Kuhn C, Schulze S, Kupka MS and Friese K: Inhibin/activin subunits alpha, beta-A and beta-B are differentially expressed in normal human endometrium throughout the menstrual cycle. Histochem Cell Biol 122: 461-471, 2004.
22. Otani T, Minami S, Kokawa K, Shikone T, Yamoto M and Nakano R: Immunohistochemical localization of activin A in human endometrial tissues during the menstrual cycle and in early pregnancy. Obstet Gynecol 91: 685-692, 1998.
23. Worbs S, Shabani N, Mayr D, Gingelmaier A, Makrigiannakis A, Kuhn C, Jeschke U, Kupka MS, Friese K and Mylonas I: Expression of the inhibin/activin subunits (-alpha, -betaA and -betaB) in normal and carcinogenic endometrial tissue: possible immunohistochemical differentiation markers. Oncol Rep 17: 97-104, 2007.
24. International Workshop on Inhibins, Activins and Follistatins. Melbourne, Australia, October 26-28, 2000. Proceedings and abstracts. Mol Cell Endocrinol 180: 1-202, 2001.